Both western blotting (Figure 1A) and immunohistochemical data suggested that ATP1A1 was significantly upregulated in high-grade gliomas (WHO grade III astrocytomas and GBMs) when compared with low-grade gliomas (grade I and, II astrocytomas) and normal human brain. The gene discussed is ATP1A1; the disease is glioma.